Hemodynamic Support Devices

This hemodynamic support systems channel includes content on intra-aortic balloon pumps (IABP), percutaneous ventricular assist devices (pVAD) like the Impella or TandemHeart, extracorporeal membrane oxygenation (ECMO), and ventricular assist devices (VAD). This channel also includes use of these devices in support of patients in cardiogenic shock and advanced heart failure

News | Ventricular Assist Devices (VAD)

May 2, 2019 — Abiomed announced that, on April 26, the U.S. Food and Drug Administration (FDA) approved initiation of ...

Home May 02, 2019
Home
Podcast | Hemodynamic Support Devices

This podcast is a discussion with William O'Neill, M.D., director of the structural heart program, Henry Ford Hospital ...

Home May 02, 2019
Home
The Aortic intra-aortic axial flow pump is designed to unload the heart and increase renal perfusion in heart failure patients experiencing cardiorenal syndrome.
Feature | Heart Failure | Will Clifton, M.D.
The heart and kidneys are inextricably linked through a diverse web of hemodynamic, neural and hormonal mechanisms. As ...
Home April 29, 2019
Home
Angiography shows a stenotic lesion in the mid right coronary artery, undilatable by standard high-pressure balloon angioplasty (inset, arrowheads). (B) Optical coherence tomography (OCT) cross-sectional (top) and longitudinal (bottom) images acquired before IVL and coregistered to the OCT lens (arrow in A) demonstrate severe near-circumferential calcification in the area of the stenosis. (C) Angiography demonstrates improvement in the area of stenosis after IVL lithoplasty.
Feature | Cath Lab | Dean Kereiakes, M.D., FACC, FSCAI, and Jonathan Hill, M.D., DISRUPT CAD III Co-Principal Investigators

Over the last 40 years, despite multiple advancements in percutaneous coronary interventions, calcified lesions remain a ...

Home April 15, 2019
Home
News | Ventricular Assist Devices (VAD)

April 5, 2019 — Three years ago this week, Abiomed's Impella heart pump received U.S. Food and Drug Administration (FDA) ...

Home April 05, 2019
Home
Illustration showing the venous implantation route and where the inlet and outflow ports are when the Abiomed Impella RP is placed in the right side of the heart. The  Impella RP catheter is used for right heart hemodynamic support.
Feature | Hemodynamic Support Devices | Perwaiz Meraj, M.D. FACC and Uma Chandrasekaran, Ph.D.

Right heart failure (RHF) is a syndrome characterized by the inability of the right ventricle (RV) to support optimal ...

Home March 26, 2019
Home
News | Ventricular Assist Devices (VAD)

March 22, 2019 — Severely ill patients with advanced heart failure who received the HeartMate 3 left ventricular assist ...

Home March 22, 2019
Home
Sponsored Content | Videos | Hemodynamic Support Devices

Perwaiz Meraj, M.D., FACC, FSCAI, director of interventional cardiology, assistant professor, Donald and Barbara Zucker ...

Home March 06, 2019
Home
Blog | Cardiovascular Surgery

Here is what I thought were the top five most important take-away presentations from the 2019 Society of Thoracic ...

Home February 25, 2019
Home
Blog | Cath Lab

Clinical study data makes the world go around in cardiology and is the basis of setting guidelines in evidence-based ...

Home February 20, 2019
Home
Sponsored Content | Videos | Heart Failure

William O'Neill, M.D., highlights best practice protocols based on Impella Quality database and real-world evidence ...

Home February 13, 2019
Home
News | Ventricular Assist Devices (VAD)

February 11, 2019 — Heart failure experts at the National Research Center for Cardiac Surgery in Astana, Kazakhstan ...

Home February 11, 2019
Home
The Abiomed Impella RP had higher than expected mortality in its post approval study, much higher than in its pre-market approval study. The vendor and the FDA believe this might be due to poor patient selection and implanting the device too late to aid the patient.
Feature | Hemodynamic Support Devices | Dave Fornell, Editor

The U.S. Food and Drug Administration (FDA) sent a letter to cardiologists this week to explain its evaluation of high ...

Home February 05, 2019
Home
The startup company Genetesis introduced a new cardiac imaging modalityit calls magnetocardiography. The scanner creates images from the biomagnetic activity of the heart, using the polarization and depolarization of the heart during the cardiac cycle. This was at AHA.18, AHA 2018 - the American Heart Association annual meeting
Feature | AHA | Dave Fornell, Editor

Here are a few of the takeaways from the clinical studies presented and new technology shown on the exhibit floor at the ...

Home January 14, 2019
Home
Sponsored Content | Videos

Mark Anderson, M.D., FACS, vice chair of cardiac surgery services and cardiothoracic surgeon at Hackensack University ...

Home January 10, 2019
Home
Subscribe Now